STAT

It’s not just Democrats: In dueling drug pricing hearings, at least some Republicans slam pharma, too

It’s not just Democrats. In Tuesday's dueling drug pricing hearings, at least some Republicans slammed pharma, too.
Rep. Jim Jordan (R-Ohio) Source: Susan Walsh/AP

WASHINGTON — Democrats here have, of late, been making far more noise about high prescription drug prices.

But at two dueling hearings on Tuesday, the most powerful Republicans on each committee made their own mark.

Rep. Jim Jordan of Ohio, the ranking member of the House Oversight Committee and a former chairman of the ultra-conservative Freedom Caucus, kicked off his panel’s hearing by offering his support for a controversial proposal that would inflame drug makers: to potentially cut the lucrative exclusivity periods the government grants drug makers for their products.

And Iowa Sen. Chuck Grassley, the chairman of the Senate Finance Committee, used part of his own speaking time

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
How Europe Is Building A Sweeping System To Study Medication Safety In Pregnant And Lactating Women
More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
STAT4 min read
Alarmed By New ‘CRISPR Babies’ Plan, Top Science Figures Say They’re Powerless To Stop It
Outraged by a new plan to create "CRISPR babies" in Russia, leading science figures concede that their organizations are powerless to stop it.
STAT2 min read
Rivals’ Disappointing Results In Asthma Trial Drag Down Shares Of AnaptysBio
Disappointing clinical trial results from Sanofi and Regeneron raise questions about the future role that certain drugs might have in treating asthma and other inflammatory related diseases.